NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 143 filers reported holding NEOGENOMICS INC in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $319,800 | -23.4% | 26,000 | 0.0% | 0.15% | -19.5% |
Q2 2023 | $417,560 | -7.7% | 26,000 | 0.0% | 0.18% | -12.7% |
Q1 2023 | $452,400 | +88.3% | 26,000 | 0.0% | 0.21% | +81.2% |
Q4 2022 | $240,240 | +7.2% | 26,000 | 0.0% | 0.12% | +3.5% |
Q3 2022 | $224,000 | +5.7% | 26,000 | 0.0% | 0.11% | +16.5% |
Q2 2022 | $212,000 | -32.9% | 26,000 | 0.0% | 0.10% | -21.8% |
Q1 2022 | $316,000 | -64.4% | 26,000 | 0.0% | 0.12% | -62.2% |
Q4 2021 | $887,000 | -29.3% | 26,000 | 0.0% | 0.33% | -35.8% |
Q3 2021 | $1,254,000 | +6.8% | 26,000 | 0.0% | 0.51% | +4.1% |
Q2 2021 | $1,174,000 | -6.4% | 26,000 | 0.0% | 0.49% | -8.4% |
Q1 2021 | $1,254,000 | -13.8% | 26,000 | -3.7% | 0.54% | -23.6% |
Q4 2020 | $1,454,000 | +46.0% | 27,000 | 0.0% | 0.70% | +25.8% |
Q3 2020 | $996,000 | +7.2% | 27,000 | -10.0% | 0.56% | +1.6% |
Q2 2020 | $929,000 | +12.2% | 30,000 | 0.0% | 0.55% | -7.1% |
Q1 2020 | $828,000 | -5.7% | 30,000 | 0.0% | 0.59% | +16.8% |
Q4 2019 | $878,000 | +53.2% | 30,000 | 0.0% | 0.51% | +40.6% |
Q3 2019 | $573,000 | -12.9% | 30,000 | 0.0% | 0.36% | -7.5% |
Q2 2019 | $658,000 | -5.3% | 30,000 | -11.8% | 0.39% | -9.3% |
Q1 2019 | $695,000 | +62.0% | 34,000 | 0.0% | 0.43% | +42.5% |
Q4 2018 | $429,000 | -17.8% | 34,000 | 0.0% | 0.30% | -8.0% |
Q3 2018 | $522,000 | +17.0% | 34,000 | 0.0% | 0.33% | +10.5% |
Q2 2018 | $446,000 | +40.3% | 34,000 | -12.8% | 0.30% | +41.6% |
Q1 2018 | $318,000 | -8.1% | 39,000 | 0.0% | 0.21% | -7.5% |
Q4 2017 | $346,000 | -20.3% | 39,000 | 0.0% | 0.23% | -22.3% |
Q3 2017 | $434,000 | +10.2% | 39,000 | -11.4% | 0.29% | +9.0% |
Q2 2017 | $394,000 | +13.5% | 44,000 | 0.0% | 0.27% | +9.9% |
Q1 2017 | $347,000 | -8.0% | 44,000 | 0.0% | 0.24% | -14.4% |
Q4 2016 | $377,000 | +4.1% | 44,000 | 0.0% | 0.28% | -5.0% |
Q3 2016 | $362,000 | +2.3% | 44,000 | 0.0% | 0.30% | -2.6% |
Q2 2016 | $354,000 | -4.6% | 44,000 | -20.0% | 0.31% | -10.0% |
Q1 2016 | $371,000 | – | 55,000 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |